Who we are
OPALIA Pharma was born from an ambitious dream, that of a Tunisian woman, Dr. Alya El Hedda, a graduate of the Faculty of Pharmacy of Paris XI Chatenay Malabry. She aimed to ensure access to therapeutic innovations for all, by balancing healthcare accessibility with international standards.
Who we are
OPALIA Pharma was born from an ambitious dream, that of a Tunisian woman, Dr. Alya El Hedda, a graduate of the Faculty of Pharmacy of Paris XI Chatenay Malabry. She aimed to ensure access to therapeutic innovations for all, by balancing healthcare accessibility with international standards.
Our purpose:
Unlocking the full potential of life
“My dream was to produce quality medicines for the most disadvantaged people. Opalia Pharma had a social and societal purpose.” Alya El Hedda, CEO of Opalia Recordati.
OPALIA Pharma is considered one of the leading generic drug manufacturers in Tunisia since 1988. For 35 years, Opalia Recordati has established itself as a pioneer in the pharmaceutical industry, entering the African market in 1993 and marking an international presence in over 25 countries across Africa and the Middle East.
Since 2013, the RECORDATI Group entered by acquiring 90% of OPALIA Pharma’s capital, thus becoming OPALIA RECORDATI, its subsidiary in Tunisia and the only one in Africa.
Founded in 1926 and headquartered in Milan, Italy, RECORDATI is an international pharmaceutical company specializing in the development, manufacturing, and marketing of medicines. Present in over 150 countries, RECORDATI focuses mainly on therapeutic areas such as cardiovascular diseases, central nervous system disorders, and rare diseases. RECORDATI is recognized for its global presence, pursuit of excellence, and commitment to innovation.
Our Structure and Our Direction
We are a group of over 400 employees who share the same passion for selflessness and work daily to improve the lives of patients by collaborating with ethics and integrity with all our stakeholders, partners, and clients.
We have always believed that health and the opportunity to live life to the fullest are a right, not a privilege. Whether it’s common or rare diseases, we want to give people the chance to be the best version of themselves